The Column Group is the investment firm named in InduPro and Circle Pharma financing histories.
Recorded funding activity
InduPro develops proximity-guided antibody-drug conjugates. Circle develops macrocycle medicines. The investor’s identity is preserved without equating unrelated TCG-labeled vehicles.
Circle Pharma discovers macrocycle medicines for cancer and other serious diseases using its MXMO platform, which combines computational, structure-based design with synthetic chemistry to create cell-permeable compounds against difficult protein targets. Its lead programs are investigational and at discovery or preclinical stages.